These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 25%It has nothing to do with investing, but this one factor is important to understand as it can create confusion. We normally don’t talk abou...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Given the raging war in the Gulf region, the volatility quotient of global markets – including India – will remain high for some time. Gett...
Possibility and probability favour them in war and peace: 10 large-cap stocks from 2 sectors with upside potential of up to 28%Probability theory is important in the stock market. Reason: Stock prices are a function of many factors and the underlying operating matri...
Being tactical not an option, but a necessity: Prescription for war and volatility; 7 pharma stocks with upside potential of up to 39%In times of major geopolitical conflicts, there is no point in looking at the day-to-day movement of the Nifty and Sensex. There are some s...
Indian or MNC pharma companies? There are reasons to look at both: 5 pharma stocks with upside potential of up to 38%Around two decades ago, as Indian pharma firms first began to move into the US market, they faced many challenges, the biggest of which was...
Combination of strong brand & higher margins equals long-term investment: 5 stocks with an upside potential of up to 23%In investing, chasing fads and short-term momentum can be tempting. But history tells us that enduring wealth is created by owning quality ...
MNC pharma: Time to relook at them? 8 pharma stocks, 4 with an upside potential of between 16 and 47%In the past four years, several MNC pharma companies announced the sale of a part of their businesses in India. Some of this was part of gl...
These 6 MNC stocks can deliver from 20 to 44% returns in 1 yearSay “multinationals operating in India”, and the companies that come to mind are the HULs and Colgates of the world. The fact, however, is ...
These 5 pharma stocks can give more than 24% returns in one yearCheck out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focu...
Advantage of large market size or annuity: 4 largecap stocks from different sectors with an upside potential of up to 22%There are some sectors where the macro structure is such that for one or the other reasons the overall growth is higher. This is not to say...
When valuations are not cheap: 5 largecap stocks from different sectors with upside potential of up to 27%It is after a long period that some of the macro factors have turned favorable for Indian markets. The recent decline in oil prices despite...
This Diwali be bullish but selectively: 7 largecap stocks with right mix of RoE & RoCEOnce again bulls have shown that while bears have the right to make a comeback attempt, bulls who have ruled the street for the last three ...
Tailwinds at the right time: 7 pharma stocks with an upside potential up to 37 %It is not very common to see tailwinds emerging for an industry at a time when it is ideal to own stocks from that space. But in the case o...
Tactical buys in time of correction? 4 MNC pharma stocks with upside potential of up to 28%In the last two decades MNC pharma companies, whose parent companies were setting up 100 percent owned subsidiaries in India and started ro...
Will they make a comeback? 4 MNC pharma stocks with upside potential of up to 28%After the IT bull of 2000, as a new set of Indian companies took the centerstage, a number of MNCs stocks lost their shine at least on the ...
Will MNC pharma stocks get back their mojo for good or is it just a blip?Most of the MNC pharma companies have formed their subsidiary and a large majority of new drugs launched in India were via this route. This...
Indian executives lose sleep to economic slowdownSales of Zolfresh, a commonly prescribed sleeping pill, has shot up from Rs 18 crore to Rs 37 crore in three years.